Miriam Glaser Heston Miriam_Glaser_Heston at
Tue Jan 6 15:46:21 EST 2004

NAS Sackler Colloquium on "Therapeutic Vaccines - Realities of Today and Hopes
for Tomorrow"
Organized by Michael Sela (Weizmann Institute of Science) and Maurice Hilleman
(Merck Institute for Vaccinology)
April 1-3, 2004; Washington, DC

Registration is now open; for further information, go to

The very notion of vaccines is prophylactic in the sense that the vaccine is
administered to healthy people to keep them from getting sick.  Nevertheless,
there is a growing trend to enlarge the notion of vaccine to therapy.  We are
striving to prepare vaccines that will alleviate the suffering of those who are
already diseased.  A great effort is being devoted to vaccines against tumors,
and so is the endeavour to fight in patients AIDS, hepatitis, or tuberculosis by
vaccines.  By definition a preventive vaccine is sufficiently similar in its
chemistry to the molecule provoking the disease so that the immune response
directed against it can act against the "troublemaker."  The situation is
analogous in the case of therapeutic vaccines.


More information about the Molmodel mailing list